FINWIRES · TerminalLIVE
FINWIRES

Cinemark Likely to Benefit From Release Slate, Wedbush Says

By

-- Cinemark (CNK) is set to benefit from a more consistent release slate over the next several quarters and further market share gains, Wedbush said in a Monday note.

"The summer slate, especially in Q3, is shaping up very nicely," the report said.

The note said theater investments, including laser projectors, premium seats and screens, IMAX expansion, and strategic pricing could drive market share gains. It also pointed to other benefits such as new builds and returning cash to shareholders.

For its Q1 results due May 1, Wedbush expects Cinemark to post Q1 revenue of $638 million, against consensus of $629 million, and a loss of $0.03 per share, against consensus of $0.16 loss.

Wedbush kept its outperform rating and a $37 price target.

Price: $29.40, Change: $+0.92, Percent Change: +3.23%

Related Articles

Sectors

Sector Update: Tech

Tech stocks were lower Monday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) decreasing 0.3% and the State Street SPDR S&P Semiconductor ETF (XSD) falling 3.9%.The Philadelphia Semiconductor index dropped 1.9%.In corporate news, Microsoft (MSFT) and OpenAI have amended their partnership under which the tech giant will no longer pay a revenue share to the ChatGPT maker, among other things, with Wedbush Securities calling the development a net positive for Microsoft. Microsoft shares were easing 0.1%.

$MSFT
Sectors

Sector Update: Health Care

Health care stocks were steady to lower Monday afternoon with the NYSE Health Care Index little changed and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.2%.The iShares Biotechnology ETF (IBB) fell 0.1%.In corporate news, Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries $14 a share in cash, valuing the company at $11.75 billion.

$OGN
Australia

Amesite Reports Direct Offering, Placement

Amesite (AMST) said on Monday it has entered into agreements for a registered direct offering and a private placement that could raise up to about $6 million for the company.The firm said it expects gross proceeds of about $2 million, and additional some $4 million if the warrants attached to the offerings of shares and pre-funded warrants are fully exercised.The offerings are expected to close around April 28, with H.C. Wainwright as the placement agent, Amesite said. It plans to use the proceeds for general corporate purposes.Price: $1.21, Change: $-0.37, Percent Change: -23.42%

$AMST